| 摘要 |
The present invention discloses a novel compound and method for the treatment of inflammatory autoimmune diseases, for example, rheumatoid arthritis, using alpha-adrenergic antagonists and beta-adrenergic agonists in combination. Treatment of animals, namely humans, with an alpha-adrenergic antagonist, preferably, phentolamine, and a beta-adrenergic agonist, preferably terbutaline, in combination can significantly suppress the joint destruction and inflammation due to disease in these animals.
|
